New dissolving stent aims to prevent dangerous leaks after pancreatic surgery
NCT ID NCT05668260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether placing a biodegradable internal stent during pancreatic surgery can prevent a common and serious complication called a pancreatic fistula. 122 high-risk patients were randomly assigned to receive the stent or no stent. The goal was to see if the stent reduces the rate of clinically relevant fistulas.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Biodegradable internal pancreatic stent (ARCHIMEDES™)
- What this could lead to
- If effective, this stent could reduce the risk of a serious pancreatic leak after surgery, leading to fewer complications and faster recovery.
- What could go wrong
- This is a small, completed study (122 patients) with no blinding. The stent may not lower fistula rates and could cause its own complications like displacement or blockage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICALLY RELEVANT POSTOPERATIVE PANCREATIC FISTULA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS Ospedale San Raffaele
Milan, Milan, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could one dose beat days of antibiotics for pancreatic surgery patients?
- Which anesthesia is safer for pancreatic surgery? new trial aims to find out
- Gut bacteria may help pancreatic surgery recovery
- New pain drug could cut opioid use after pancreatic surgery
- Special stitches aim to stop pancreatic leaks after major surgery